From Computational Hypothesis to Validated Leads
Lead discovery chemistry transforms early biological targets into chemically defined, experimentally validated lead candidates. In modern drug development, this journey spans computational hit identification, rational molecular design, and the synthesis and validation of promising compounds—each stage demanding specialized expertise and tight integration between in silico and experimental workflows. At Profacgen, we unify these capabilities into a single, efficient lead discovery platform that shortens design-make-test-analyze cycles and improves the quality of candidates advancing into preclinical development.
Profacgen's Lead Discovery Chemistry services cover the full arc from virtual screening through experimental lead validation. Each module can be engaged independently or combined into an integrated program tailored to your target, modality, and stage of development:
Computationally identify hit molecules from large compound collections using ligand-based, structure-based, hybrid, and quantum-mechanics approaches. Our virtual screening suite encompasses 2D/3D similarity, pharmacophore modeling, 3D-QSAR, molecular docking, and ADMET prediction—enabling rapid, cost-efficient hit discovery even when structural information is limited.
Design and model nucleic acid aptamers with high affinity and specificity for proteins, small molecules, cells, or other targets. Using sequence optimization, structure prediction, and molecular docking of aptamer–target complexes, we accelerate the development of aptamer-based reagents for diagnostics, detection, and therapeutic applications.
Translate computational predictions into experimental confidence through custom peptide and small-molecule synthesis coupled with biochemical and biophysical validation. Our integrated workflow delivers purified, fully characterized compounds and confirm their activity, selectivity, and developability—closing the loop between in silico design and lead progression.
The three pillars of our Lead Discovery Chemistry platform are designed to connect seamlessly. Virtual screening generates prioritized candidates; in silico aptamer design extends molecular recognition tools to nucleic-acid modalities; and lead validation with synthesis support confirms activity and delivers test-ready material. Together they form a continuous optimization loop that reduces attrition, controls cost, and accelerates the path from target to development candidate. Contact us to discuss your Lead discovery program.
References:
Fill out this form and one of our experts will respond to you within one business day.